Compare KVUE & VRSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Verisk Analytics is a leading provider of data analytics and proprietary solutions supporting clients within the insurance ecosystem. Verisk operates under a single segment with two separate business units, underwriting and claims. Within underwriting, the company operates as both a statistical agent and advisory organization collecting and aggregating industrywide claims and policy data and providing insurers with pre-approved forms, rules, and loss costs. Aside from their regulatory and compliance offerings, Verisk provides specialized solutions utilized to power P&C underwriting and catastrophe risk assessment used in reinsurance and insurance-linked securities. Verisk's smaller claims business is critical in preventing fraud and estimating property insurance claims.